Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Compliance seeking

In compliance with the requirements stated in the System of accreditation to the practical experience and qualification the technical manager in NDT must have at least level 2 on each of NDT methods used in the laboratory seeking accreditation, where not more than 3 NDT methods are in practice, and level 3 on the basic method used in the laboratory where there are more than 3 methods. Moreover all specialists must be certified in relevant NDT method and industrial sector. [Pg.957]

The citizen suit provisions have also been revised to allow citizens to seek penalties against violators, with the penalties going to a U.S. Treasury fund for use by EPA for compliance and enforcement activities. The U.S. government s right to intervene is clarified and citizen plaintiffs will be required to provide the U.S. government with copies of pleadings and draft settlements. [Pg.404]

Sometimes you can use your legally mandated course of action to leverage a voluntary admission on the part of a client. If you remind the client that you are now bound to report the incident if she or he is not willing to seek help, then frequently the client will acquiesce and voluntarily seek help. Your responsibility is to make certain that the client actually follows through rather than simply feigning compliance. Obviously this outcome is preferred, since it helps to preserve the therapeutic alliance, whereas an involuntary commitment often harms your relationship with a client. [Pg.129]

Physicians reported mixed feelings about the impact of DTCA on their patients and practices— More than 70 percent felt that DTCA helped educate patients about available treatments 67% felt that DTCA helped them have better discussions with their patients, ffowever, four out of five doctors believed that DTCA did not provide information in a balanced manner, and a similar number felt that it encouraged patients to seek treatments they did not need. Physicians as a group were more equivocal about other impacts of DTCA, with 46 percent agreeing that it increased patients compliance and 32 percent that it made patients less confident in their doctors judgment. Overall, 40 percent felt that DTCA had a positive effect on their patients and their practices, 30% felt it had a negative effect, and 30% felt that it had no effect. ... [Pg.188]

Maintenance antidepressants must be given in adequate dosages to sustain euthymia, and discontinuations may increase risk of relapse. Thus, compliance is essential if maintenance antidepressants are to work. Too few studies have paid adequate attention to reasons for noncompliance or lack of adherence [Axelrod and Wetzler 1989 Kelly et al. 1990 Meichenbaum and Turk 1987 L. S. Morris and Schulz 1992], but it appears to be most influenced by side effects, although for some patients, cost is a significant variable. In seeking to enhance adherence, clinicians must select a medication at the beginning of treatment that patients will find acceptable for years or decades to come. [Pg.325]

As Geiser stated (Geiser, 1998), the P2 movement differed dramatically and fundamentally from the conventional command and control, end-of-pipe, media-specific, compliance and enforcement system that was dominant in environmental protection policy during the 1980s. The P2 movement has been slow to develop the internal capacities that would promote the environmental successes that the pollution prevention concept offers. Geiser laid out five uncompleted tasks in the promotion of pollution prevention (Geiser, 1995). The current text seeks to address only one of these the chemical substitutes for existing chemicals. [Pg.5]

Compliance to FDA regulations by the health care industry over the last decade has been a major goal, including those companies intending to export their product to the U.S. market. As a result, only a few companies are able to seek approval for exportation one of the reasons behind this is the absence or inadequacy of validation SOPs. [Pg.1132]

In achieving this target, all countries should seek common, science-based, international standards. FSIS should continue to ensure that equivalent inspection systems and standards for meat and poultry products exist in all countries exporting such products to the United States, especially in light of the better US safety standards expected under Hazard Analysis Critical Control Points (HACCP). FDA also should evaluate the food safety systems of other countries, with the purpose of entering into agreements with those countries having food safety systems that offer equivalent levels of public health protection to those of the United States or that can provide assurance that their products will be in compliance with FDA requirements. [Pg.439]

Where organizations wish to implement quality management systems in conformance with modules E, D, or H, they may use EN ISO 9001 2000. In seeking compliance with modules D, E, or H, an organization may exclude specific requirements. [Pg.13]

Given the abundance of water-insoluble or poorly water-soluble drugs as well as drugs exhibiting other development challenges such as metabolic and enzymatic instability, the pharmaceutical industry continues to seek solutions to overcome these limitations to develop innovative, clinically safe, and patient-friendly products. As said earlier, MR delivery products offer tremendous advantages with respect to therapeutic indices, pharmacoeconomics, and patient compliance. In addition,... [Pg.631]

Compliance with Part 11. Whether the firm is seeking approval for a pharmaceutical, biologic, or medical device product, compliance with... [Pg.482]

Although not specified in the FDC Act, internal audit data as it relates to compliance with cGMP requirements, are typically not subject to FDA review, but the agency might seek confirmation that audits were performed. FDA has described situations, such as a for-cause inspection or during litigation, in which it might seek a review of this type of information. [Pg.555]

While the benefits of FDA s fast track approval and accelerated approval procedures are described in Chapter 1, it should be noted that a company seeking to use this option must also expedite its preparation for preapproval inspection and GMP compliance. Because FDA signoflf of the manufacturing facility will likely be required for NDA approval and such signoflf is to be accelerated, a firm must recognize that expedited compliance is necessary for this expedited review and have its own manufacturing house in order. [Pg.573]


See other pages where Compliance seeking is mentioned: [Pg.21]    [Pg.68]    [Pg.146]    [Pg.193]    [Pg.21]    [Pg.68]    [Pg.146]    [Pg.193]    [Pg.8]    [Pg.339]    [Pg.484]    [Pg.16]    [Pg.280]    [Pg.191]    [Pg.751]    [Pg.439]    [Pg.180]    [Pg.65]    [Pg.69]    [Pg.229]    [Pg.300]    [Pg.323]    [Pg.362]    [Pg.404]    [Pg.60]    [Pg.115]    [Pg.423]    [Pg.437]    [Pg.1142]    [Pg.57]    [Pg.331]    [Pg.243]    [Pg.425]    [Pg.243]    [Pg.339]    [Pg.339]    [Pg.183]    [Pg.473]    [Pg.488]    [Pg.509]    [Pg.599]   
See also in sourсe #XX -- [ Pg.21 , Pg.40 , Pg.60 , Pg.66 , Pg.68 , Pg.73 , Pg.106 , Pg.116 , Pg.118 , Pg.119 , Pg.146 , Pg.191 ]




SEARCH



© 2024 chempedia.info